2 not yet recruiting, 2 recruiting, 1 completed. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Acute Severe Ulcerative Colitis: new trials by email Literature Review of Acute Severe Ulcerative Colitis trials Research Report on Acute Severe Ulcerative Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE) upadacitinib, Infliximab - Acute Severe Ulcerative Colitis | Phase 4 | Recruiting | Xijing Hospital of Digestive Diseases | 226 | 2026-04-20 | 2026-04-24 |
| Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT) Upadacitinib, Corticosteroid - Acute Severe Ulcerative Colitis | Phase 4 | Recruiting | Yongquan Shi | 46 | 2026-03-23 | 2026-06-15 |
| Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial Infliximab, Tofacitinib - Acute Severe Ulcerative Colitis | Phase 2 | Not yet recruiting | Asian Institute of Gastroenterology, India | 60 | 2026-01-01 | 2025-12-24 |
| Cohort of Patients With Ulcerative Colitis or Polyps Followed in CHU de Bordeaux Associated With a Biocollection - COLIBRI Blood sample, biopsy - Ulcerative Colitis, Inflammatory Bowel Disease (IBD) | Not applicable | Not yet recruiting | University Hospital, Bordeaux | 200 | 2025-09-01 | 2025-07-24 |
| Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis Upadacitinib - Ulcerative Colitis (UC), Acute Severe Ulcerative Colitis | Completed | Xijing Hospital of Digestive Diseases | 81 | 2023-06-06 | 2026-03-16 |
Colitis, Ulcerative (2) · Inflammatory Bowel Diseases (1)
Colitis (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Inflammatory Bowel Diseases (1)
upadacitinib (3) · Infliximab (2) · Adrenal Cortex Hormones (1) · Biopsy (1) · Blood Specimen Collection (1) · tofacitinib (1)
Xijing Hospital of Digestive Diseases (2) · Asian Institute of Gastroenterology, India (1) · University Hospital, Bordeaux (1) · Yongquan Shi (1)
China (3) · France (1) · India (1)